Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will TxGNN identify at least one FDA-approved drug repurposed for rare diseases by end of 2024?  | Binary | 2 | 3 months ago | ||
Will TxGNN lead to a new clinical trial for a rare disease by mid-2024? | Binary | 2 | 3 months ago | ||
Will TxGNN model's findings be featured in another high-impact journal by end of 2024? | Binary | 2 | 3 months ago | ||
Which FDA-approved drug will be the first repurposed by TxGNN for a rare disease? | Categorical | 2 | 3 months ago | ||
Which rare disease category will benefit first from TxGNN's drug repurposing? | Categorical | 2 | 3 months ago | ||
Which institution will primarily collaborate with Kempner Institute on TxGNN by end of 2024? | Categorical | 2 | 3 months ago |